Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA’s OTC Drugs Advisory Committee

Executive Summary

Dec. 16-17 inaugural meeting will be held at the Holiday Inn- Bethesda beginning at 8 a.m. each day. On Dec. 16, the committee will discuss its role in regulation of OTC drug products. On Dec. 17, the group will discuss "the presence of alcohol in oral OTC drug products intended for ingestion by adults and children," including the types of products, "the pharmaceutical role of alcohol, possible content limitations, and non-alcohol formulation alternatives" ("The Pink Sheet" Nov. 16, p. 3).
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS021831

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel